Lifeward (LFWD) Other Non-Current Assets (2014 - 2026)
Lifeward (LFWD) reported Other Non-Current Assets of $609000.0 for Q1 2026, up 213.92% on a YoY basis from $194000.0 in Q1 2025, and up 153.75% sequentially from $240000.0 in Q4 2025.
Lifeward (LFWD) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Lifeward (LFWD) has 13 years of Other Non-Current Assets data on file, last reported at $609000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 213.92% year-over-year to $609000.0; the trailing twelve-month figure through Mar 2026 stood at $609000.0 (up 213.92% YoY), and the FY2025 full-year result was $240000.0, up 21.83% from the prior year.
- Other Non-Current Assets improved to $609000.0 in Q1 2026, from $240000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.1 million in Q1 2022 to a low of $194000.0 in Q1 2025.
- A 5-year average of $555437.5 and a median of $522500.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets plunged 55.09% in 2025 and soared 213.92% in 2026, its largest moves.
- Tracing LFWD's Other Non-Current Assets over 5 years: stood at $694000.0 in 2022, then grew by 11.24% to $772000.0 in 2023, then plunged by 74.48% to $197000.0 in 2024, then advanced by 21.83% to $240000.0 in 2025, then surged by 153.75% to $609000.0 in 2026.
- Business Quant data shows LFWD's Other Non-Current Assets at $609000.0 in Q1 2026, $240000.0 in Q4 2025, and $205000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | 609,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 609,000.00 |
| Dec 31, 2025 | 240,000.00 |
| Sep 30, 2025 | 205,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Mar 31, 2025 | 194,000.00 |
| Dec 31, 2024 | 197,000.00 |
| Sep 30, 2024 | 436,000.00 |
| Jun 30, 2024 | 430,000.00 |
| Mar 31, 2024 | 432,000.00 |
| Sep 30, 2023 | 772,000.00 |
| Jun 30, 2023 | 689,000.00 |
| Mar 31, 2023 | 692,000.00 |
| Dec 31, 2022 | 694,000.00 |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | 1.04 Mn |
| Mar 31, 2021 | 1.02 Mn |